Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,400.96
(
-0.16%
)
US TECH 100
28,481.53
(
0.68%
)
Dow Jones
49,760.56
(
0.00%
)
Brent Oil
105.50
(
-0.25%
)
Bitcoin
80,377.88
(
-0.14%
)
News Focus
News Focus
Post# of 347009
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Couch

Send PM Follow Ignore
Followers 280
Posts 31200
Boards Moderated 0
Alias Born 07/06/2012

Couch

Re: biopharm post# 279949

Wednesday, 11/30/2016 8:15:44 PM

Wednesday, November 30, 2016 8:15:44 PM

Post# of 347009

The FDA can approve it, based on a high, unmet medical need with no other comparable biomarkers for NSCLC.


I imagine that is what Garnick is trying to figure out - what type of trial will justify this to the FDA as quick as possible???

Fear Uncertainty and Doubt FUD It Ain't Going To Work Here Anymore. Notice the lack of question mark.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote